- William F. Regine, MD
The Isadore & Fannie Schneider Foxman Endowed Chair in Radiation Oncology
For more than 50 years, the University of Maryland Department of Radiation Oncology has been caring for those whose lives have been threatened by a diagnosis of cancer. Whether those patients live in Baltimore or travel from their homes around the world, they know that they will be receiving the finest of care, from the most state-of-the-art technology to the skilled and compassionate healing offered by every member of the Radiation Oncology faculty and staff.
Our department manages every type of cancer, providing a depth of experience that makes the University of Maryland not only the right place to receive care, but an ideal professional career as well. The extraordinary pace of our recent progress has resulted from intellectual synergy and a shared, relentless ambition to deliver the highest quality of care to patients.
The University of Maryland Department of Radiation Oncology has three locations, which include the University of Maryland Medical Center; Central Maryland Radiation Oncology in Columbia, MD; and the Tate Cancer Center at Baltimore Washington Medical Center. Each site is staffed with University of Maryland faculty. This affiliation opens the door to leading-edge treatment modalities, cutting-edge clinical trials and expert consultation with University of Maryland Greenebaum Cancer Center physicians.
Excellence in our educational mission is pursued through many avenues: the rotation of medical students through our program; our residency program, which includes eight residents; our radiation therapy program; and our dosimetry school, which is accredited by the Joint Review Committee on Education in Radiologic Technology (JRCERT). This program is only one of twelve programs in the United States to achieve such accreditation.
The Department’s focus on promoting translational research includes integration of our radiobiology, physics and clinical divisions, as well as with the University of Maryland Marlene and Stewart Greenebaum Cancer Center and other basic science departments. Our physicians, physicists and basic science researchers are nationally recognized leaders in discovering new and better ways to treat cancer with radiotherapy.
As we move forward, our past present and future can be summarized by our Departmental Vision and Mission Statement:
Inspired by our patients and driven by passion:
To be leaders in defining state-of-the-art care to patients and caregivers by way of collaboration within and beyond the discipline of Radiation Oncology, and through
our tireless focus on clinical service, research, education, and community outreach.
“It is who we are, it is what we do, it is what leaves us feeling there is more work to be done at the end of each day, and it is what drives us towards greater achievements at the start of each day.”
Maryland Proton Treatment Center
The University of Maryland School of Medicine and its development partner Advanced Particle Therapy LLC of San Diego, Calif., have begun construction on the Maryland Proton Treatment Center, a more than $200 million project that brings to Maryland for the first time the most advanced radiation technology in cancer treatment. Below is a real-time view of the construction site. Learn More About This State-of-the-Art Center
Topping Out Ceremony
The Maryland Proton Treatment Center celebrated its "topping out" with a ceremony at the building's site on January 17, 2013.